Ingevity Corporation (NYSE:NGVT) Stock Has Average Target Price of $80.00

Shares of Ingevity Corporation (NYSE:NGVT) have received an average rating of “Hold” from the five ratings firms that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $80.00.

A number of research firms have commented on NGVT. Weiss Ratings upgraded Ingevity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st.

Ingevity Price Performance

Shares of NYSE:NGVT opened at $70.57 on Friday. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. Ingevity has a 52 week low of $45.85 and a 52 week high of $79.29. The firm has a market cap of $2.43 billion, a PE ratio of 14.67 and a beta of 1.14. The firm’s fifty day moving average is $71.08 and its 200-day moving average is $71.88.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Sell-side analysts predict that Ingevity will post 5.40 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO David H. Li sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the sale, the chief executive officer directly owned 120,636 shares in the company, valued at $9,147,827.88. This represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan C. Fisher sold 2,709 shares of the stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares of the company’s stock, valued at $1,159,025.84. This represents a 14.70% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 17,801 shares of company stock worth $1,347,481. 0.88% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NGVT. Assetmark Inc. boosted its stake in shares of Ingevity by 9.6% in the 1st quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock valued at $113,000 after purchasing an additional 139 shares during the last quarter. Frazier Financial Advisors LLC acquired a new stake in shares of Ingevity during the second quarter worth $37,000. Evolve Private Wealth LLC raised its stake in Ingevity by 10.2% during the first quarter. Evolve Private Wealth LLC now owns 5,946 shares of the company’s stock worth $424,000 after buying an additional 549 shares during the last quarter. Lazard Asset Management LLC raised its stake in Ingevity by 6.3% during the first quarter. Lazard Asset Management LLC now owns 9,262 shares of the company’s stock worth $660,000 after buying an additional 549 shares during the last quarter. Finally, Global Retirement Partners LLC bought a new position in Ingevity during the second quarter worth $45,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. The company develops products designed to improve environmental performance, enhance infrastructure and support industrial manufacturing.

Ingevity’s products include activated carbon technologies used in automotive evaporative-emissions control systems, as well as applications involving air and water purification. The company also produces specialty chemicals and materials used in pavement preservation, asphalt modification and other industrial applications.